Literature DB >> 217889

Androgen biosynthesis in human ovarian follicles: cellular source, gonadotropic control, and adenosine 3',5'-monophosphate mediation.

B K Tsang, Y S Moon, C W Simpson, D T Armstrong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 217889     DOI： 10.1210/jcem-48-1-153

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Follicle stimulating hormone effects on immature human oocytes: in vitro maturation and hormone production.

Authors:  K L Durinzi; A C Wentz; E M Saniga; D E Johnson; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  1997-04       Impact factor: 3.412

2.  Expression of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; S Fujii; Y Nanbu; H Nonogaki; I Konishi; T Mori; H Masutani; J Yodoi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells.

Authors:  E M Pérez-Armendariz; J Luna; C Miranda; D Talavera; M C Romano
Journal:  Endocrine       Date:  1996-04       Impact factor: 3.633

4.  Granulosa and thecal cells from human ovarian follicles under growth: steroid formation in vitro and responsiveness to human chorionic gonadotropin.

Authors:  L Nilsson; B Dennefors; L Hamberger
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 5.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

6.  Significance of atretic follicles as the site of androgen production in polycystic ovaries.

Authors:  T Mori; Y Fujita; K Nihnobu; T Aso; Y Sakamoto; T Nishimura
Journal:  J Endocrinol Invest       Date:  1982 Jul-Aug       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.